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1998 Lesbian and Gay Law Conference
AIDS Policy and the Fight
Against AIDS Discrimination
Jim Williams, Esq.*
MR. WILLIAMS: Welcome to our panel on AIDS Policy and
the fight against AIDS discrimination. We have a distinguished panel
with us here today. I would like to introduce them to you.
To my left is Jennifer Middleton. Jennifer is a staff attorney at
the ACLU Lesbian and Gay Rights and HIV AIDS Projects, where she
represents people with HIV infection through policy advocacy and
impact litigation under the Americans with Disabilities Act, the
Rehabilitation Act and various confidentiality provisions under federal
and state law. Most recently, she co-authored the ACLU'samicus brief
in Bragdon v. Abbott,' the U.S. Supreme Court case considering whether
people with asymptomatic AIDS and HIV are covered under the ADA.
Next to Jennifer is New York State Assembly Member Richard
Gottfried. Richard Gottfried has been the Chair of the New York State
Assembly's Committee on Health since 1987. He was the author of the
landmark 1988 HIV testing and confidentiality law and continues to lead
the fight to protect it. He led the effort that won state funding to restore
cuts in the AIDS Drug Assistance Program in 1996. He was an architect
of the 1996 Managed Care Consumer Bill of Rights Law and sponsored
further legislation for managed care reform. Among his legislative
priorities are: universal healthcare coverage, reproductive freedom and
funding for HIV prevention and services. He has been a sponsor of a bill
to ban discrimination based on sexual orientation since it was first
introduced in 1971. He is consistently on the New York Civil Liberties
Union's annual legislative honor role. His assembly district includes
Chelsea, Clinton, Midtown and parts of Murray Hill and the Lincoln
Center area. He is a lawyer, but he does not maintain a private law
Jim Williams is former president of LeGaL. He is the Executive Director of
the National Employment Law Project, a public interest law firm that advocates for the
employment rights of low-wage workers and the unemployed.
'118 S. Ct. 2196 (1998) (decided June 25, 1998).
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practice.
Next to Assembly Member Gottfried is NinaLoewenstein. Nina
is a staff attorney HIV/AIDS legal services at the Legal Aid Society of
Rockland County, serving the diverse communities of low-income
Rockland County residents. A significant part of her current work has
been civil rights litigation on behalf of HIV positive clients and adult
residential care and women's health, as well as efforts to enforce
confidentiality protections under Article 27F.2 She holds degrees in
public health as well as law, and is currently a member of the New York
City Bar Association's working group on HIV testing, privacy and
confidentiality.
Next to Nina is Kimberly Mutcherson. She is currently a
Kirkland and Ellis Fellow at the HIV Law Project. The Law Project is
a small, not-for-profit organization that provides free legal services for
HIV positive individuals, with a particular emphasis on serving under-
served populations, including women of color, injection drug users and
low income gay and lesbians. She is a full time attorney in the
Reproductive Rights Project and is working extensively on the issue of
mandatory HIV testing of newborns and other issues affecting HIV
positive women.
We have prepared a series of questions for each of the panelists.
Once we have gone through the questions, we willopen up questions to
the audience.
Jennifer, why is there so much discussion currently about
instituting name-based recording systems of people with HIV infection,
and what is the status of these proposals?
Jennifer Middleton, Esq.
MS. MIDDLETON: I will start just by giving an overview of
what is happening with name recording to date. I think Assembly
Member Gottfried might give a pros and cons vision.
2 N.Y. PuB. HEALTH LAW §2782 (Consol.1999). Article 27-F maps out to
whom, when, and how someone in New York State may disclose confidential information
regarding HIV and AIDS patients. It also delineates requirements for pre-test and post-test
counseling and written informed consent prior to HIV testing.
484 [Vol. XV
1999] AIDS AND DISCRIMINA TION 485
The proposals that are floating out there are being called a
nationwide system of name recordings of people with HIV.3 What that
means is that any time someone took an HIV test and it came back as
positive, the testing center or the person's doctor or the lab would have
to report the name of the person along with other relevant information-
age, neighborhood, race, sex, risk activity, etc. - to the State Department
of Health. That information would be maintained in a database to track
the spread of the epidemic. It would be used purely for public health
efforts to determine where to target funding for the epidemic and how the
face of AIDS, as they say, is shifting.
Name reporting is not new. When AIDS and HIV first arrived
and was recognized in the early eighties, the Centers for Disease Control
(CDC) mandated AIDS recordings taken by the state' So, when people
got an AIDS diagnosis, meaning when their CD4 counts were below two
hundred, or they manifested symptoms, their names would be reported
to the State Department of Health, which would then to go the CDC.
That system currently exists and has been around ever since the
beginning of the epidemic. Civil libertarians were somewhat opposed to
this, but recognized that once people developed AIDS and were seeking
treatment through the healthcare system, they had pretty much lost most
of their confidentiality in their HIV status. In fact, in the beginning,
'See Mark Schoofs, What's in a Name? VILLAGE VOICE, Apr. 7, 1998, at 36
(discussing a bill pending in Congress mandating a national system listing the names of
people with HIV); see also Thomas Henderson, Name Debate Complicates HIV Tests,
DALLAS MORNING NEWS, Mar. 8, 1998, at 6J (discussing the President's Advisory Counsel
on HIV/AIDS, which expressed serious doubts about a "national HIV names reporting
surveillance system").
4 See generally CENTERS FOR DISEASE CONTROL, DRAFT GUIDELINES FOR
NATIONAL HIV CASE SURVEILLANCE, INCLUDING MONITORING FOR HIV INFECTION AND
ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) (updated Dec.. 10, 1998) (visited July 19,
1999) available at <http://www.cdc.gov/nchstp/hiv-aids/pubs/rifr/rrfrrep.
html> (hereinafter "CDC DRAFT GUIDELINES") "Since 1981, population-based AIDS
surveillance.., has been used to track the progression of the HIV epidemic." Id. at 2. The
CDC paper goes on to note that "As of October 1, 1998, 32 States had implemented HIV
case surveillance" and that surveillance, both at national and state levels "is conducted using
the name-based methods for case ascertainment that are used by other public health
information systems." Id. at 2, 4. See also Jonathan Curiel, U.S. Asks States to Report
People Who Take HIV Tests S.F. CHRONICLE, Dec. 10, 1998, at Al (discussing that the CDC
requires states to report HIV cases and now would like mandatory repohing of AIDS cases).
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many people did not realize they had HIV until they developed AIDS.
So, there was less of a concern about confidentiality during the time that
people were positive, but asymptomatic, among those who preferred
maintaining secrecy up until they developed symptoms.
There have been name based AIDS recordings since the
beginning of the epidemic, and that has been sufficient up until now for
the public health people. There has been some debate about this system,
but it has basically been an AIDS-based reporting system. It has allowed
epidemiologists to determine what is happening with the epidemic,
because it provided a snapshot of who had AIDS at a certain moment in
time, from which they could adopt health efforts and could extrapolate
where the disease was going.
The public health people have also done what are calledsero-
prevalence studies in hospitals.' In these studies, they do anonymous
testing among hospital patients in certain populations. Results are not
disclosed to the people tested. This testing is random to determine
incidental levels in identified populations. It is really through a variety
of these different kinds of methods that there has been public health
surveillance of who had HIV.
Now, in the wake of new treatments, the public health
community is saying that it needs to know more than just the number of
AIDS cases. They argue that they need to know HIV cases, as well,
because people are on medication that is keeping them from becoming
sick and developing AIDS for years and years. Those individuals are not
counted in the current system, because they have not developed AIDS.
So, we do not know what is happening in terms of the spread of HIV the
way we used to be able to tell by looking at who developed AIDS.
The ACLU has not taken a position on whether in fact some kind
'See CENTERS FOR DISEASE CONTROL, AIDS AND HUMAN IMMUNODEFICIENCY
VIRUS INFECTION IN THE UNITED STATES: 1988 UPDATE (updated May 12, 1988) (visited July
12, 1999) available in <http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/O0001477.htm>.
As an ongoing process, the CDC, in conjunction with "other federal agencies, state and local
health departments, blood-collection agencies, and medical research institutions, has
undertaken a multifaceted 'family' of complementary HIV surveys." Id. at I. These surveys
are undertaken to provide information on "HIV seroprevalence" which is defined as "the
prevalence of HIV infection as measured by the presence of HIV antibodies in the blood."
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of case recording system is necessary. We have left that to the public
health experts. What we have said is that a name-based system for doing
that is not necessary. Currently twenty states have name-based recording
6
systems. Two states have systems where they use unique identifiers,
Texas and Maryland. There they report HIV cases to the State
Department of Public Health, but they do not use the person's name.7
The remaining twenty-eight states have no recording system whatsoever.
The twenty states that have name recording are generally the low-
incidence states. California and New York, who have the two highest
incidences of HIV, do not have any type of recording system.
The difference between the two systems, name based and unique
identifier, is that in the names based system, the state gets the names and
can maintain a roster of everyone who has HIV. What this means is that
it can do things like, for example, what happened in Illinois. There, the
state legislature proposed that the state cross-reference the names of
people infected with HIV with the names of everyone who applied for a
professional medical license. That legislation actually passed, but then
in a moment of incredible luck the legislature chose not to fund it, so it
never actually happened.
In name based systems, a thing like that could potentially
happen. In unique identifier systems, the anonymity of the patient is
retained; it is not easy to go back and match the identifiers with the
names. Also, under a unique identifier system, if the data were to leak
somehow; if, for example, some state employee walked off with a
computer disc, the thief would not be able to ascertain whom the HIV
positive individuals were. That is the background to the current debate.
MR. WILLIAMS: Assembly Member Gottfried, could you give
us your views on the merits and prospects of the reporting versus unique
identifier or some other system?
6 Compare CDC DRAFT GUIDELINES, supra note 4, at 3. At the time the
guidelines were published the CDC reported that 32 States had name based HIV surveillance.
'See Lillian Lee Kim, Health Watch: CDC Wants to Track AIDS Using Names
of all Patients, ATLANTA JouRNAL AND CoNsTITUTION, Dec. 11, 1998, at 3F. Maryland and
Texas use numerical codes instead of names to report HIV infections. Id.
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Assemblyman Richard Gottfried
MR. GOTTFRIED: The argument for developing case reporting
of HIV as opposed to AIDS has a lot to be said for it. If someone who
is infected today may not become symptomatic for years down the road,
or if there is a shift in the demographics of the epidemic or the geography
of it, it is valuable to know that so that we can respond with public
policies. If we do not have HIV reporting, we will not find out about the
shift arguably for another five or ten years. Not that we have done a
whole lot with the information we now have, but at least we would have
that opportunity.
Traditionally in public health, if epidemiologists wanted to track
a disease, there was a lot to be said for giving them precision in doing
that. For example, if a case of cholera were reported to the Health
Department and the address was 47 Worth St., people from the Health
Department would rush here to New York Law School; would test the
water; and would want to know where the person who had the cholera
lived. Then, they would rush to that person's block and test the water
that person is drinking, because cholera is spread primarily by dirty water
supplies. They would want to know where that water supply was so you
could shut it down and clean it out. Knowing that there are three cases
of cholera in Manhattan or that there are ten Asians or ten Hispanics in
Manhattan with cholera is not good enough. You need to know exactly
where they live. Likewise, if there were three cases of measles among the
student body at the New York Law School, they would rush right down
here and immunize everybody and find people who were in the same
class together or were studying together. They might try to encourage
you to be quarantined in your homes and the like. Again, knowing that
there was a growth in the number of measles cases in Manhattan would
not be good enough.
On the other hand, if they find out there are three more cases of
HIV in the New York Law School student body, nobody is going to run
out and try to shut down your law school or do any of those sorts of
health responses. They might try to do some education among the student
body. But given the differences in the way HIV is spread from most other
diseases, a person here at New York Law School might have been
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infected in Timbuktu. The data that we need to know to track the trends
of the epidemic, it does not really make much difference whether forty
or forty-two percent of the HIV cases are one thing or another. We need
to know whether it is forty or eighty.
Another critical difference between HIV and most other diseases
is that the time between when you are infected and can infect others,
versus when you develop symptoms and need treatment, is years. That
is significant, because when people develop symptoms, you can usually
rely on their desire for treatment to bring them in. If somebody has a
germ in them but feels fine, they are not going to come in, unless you
draw them in and refrain from scaring them away. That is why men do
not get prostate tests and women do not get mammograms unless we drag
them in somehow. You have to look at whether the way you conduct
those exams will frighten people away or encourage them to say, "Well
it is probably not me, so I won't get tested."
That is where you come to the issue of name reporting versus a
coded unique identifier system. With name reporting, the case for it is
that there is some allegedly enhanced precision. The claim is that you do
not count somebody twice, you know who you are counting. My
response to that is twofold. Number one, you do not need that level of
precision for HIV case recording. It does not matter all that much
whether you counted a hundred people or a hundred and six people.
Number two, you really do not get that kind of accuracy from name
reporting. It is a false illusion. Just like an inaccurate digital watch says
it is 6:53 and 7.2 seconds. You look at your watch and you say, wow,
this is terrific. My old watch did not tell me how many tenths of a second
it was past 6:53. Of course, it is really four o'clock in the afternoon.
Your digital watch gave you the illusion that it is 6:53 and 7.2 seconds.
So, you take great confidence from this precision, but it is phony.
If what is reported is Nina L-O-E-W-E-N-S-T-E-I-N,the person
typing that in said, well this is great. I know precisely whom I am
punching in. But, of course, he misspelled her name "L-O-W." So, is
that the same person as "L-O-E-W" or a different person?
MS. LOEWENSTEIN: A very common mistake.
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MR. GOTTFRIED: In fact, I bet it has happened once or twice
in your life. Is Bob Jones the same as Robert Jones and the same as
Bobby Jones? Or, if you get those three names reported, are you over-
counting? With name reporting, you get this illusion that you are not
over-counting when in fact you are.
The biggest loss of precision in name reporting is that under any
system, the only people you can count are the people who have chosen
to come in and be tested at a non-anonymous site or a site where they
know your name. If people, as a result of name reporting, are afraid to
add their name to the government computer - a common fear among
Americans in general, especially people with HIV, or especially people
who engage in one of the various behaviors that puts you at risk of HIV;
if they come in and say, my name is Ronald Reagan or some other name
or do not come in at all; or only get tested at an anonymous site, you have
blown the precision of your testing system. That is especially true if
people of one particular demographic or another are more frightened of
having their name in the computer than other people, because then that
group, whichever one it is, will be even more heavily under-represented
than every other group. So, if you say, well, we will have five percent of
all the numbers. If one group is twenty percent under-represented, and
five points in every group will be withheld.
To me, that is the big problem with name reporting. It will drive
people away from being tested, especially from being tested by a
healthcare provider who knows who they are. So, people will be out
there infected and infecting without knowing it, or they may know it, but
a healthcare provider who could talk to them about the wisdom of contact
notification and the wisdom of using condoms and whatever else, will
have no way of talking to them. Name reporting is worse than not very
valuable. I think it is a public health menace.
One of the alternatives is the coded unique identifier system in
which we develop a code. Say, maybe it is the first two letters of your
first name and the last three letters of your last name and the three middle
digits of your social security number. That will be your unique identifier,
which makes it highly likely that no two people will have the same
unique identifier, and yet somebody looking at that will have pretty much
no way of knowing who you are. Now, if you took that information and
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you had access to the Social Security Administration's records, you could
very quickly find out that I was RIIED461. But, if we put in legislation
that the computer tapes cannot be matched with the Social Security
Administration then we can pretty much prevent that from happening.
What are the prospects? I think there is a big steam engine
chugging down the tracks for name reporting. It has a lot going for it
politically. Part of it is a general desire by people in my line of work to
control everybody else. Nobody likes being controlled. But there are an
awful lot of people in government who love to control everybody else.
Name reporting is a big step forward in that direction. There is also the
illusion of precision. There is also the prospect that if we do not go to
name reporting, the Center for Disease Control is going to take money
away from us.
There is also the notion that if the government has the name and
address of everybody who is HIV positive, then when new cures are
developed, government bureaucrats will fan out across the city and reach
out to these people and give them the good news that they can be helped
They contend that if all we have is these unique identifiers, we will not
be able to come out and help you. This buys into the joke about the three
greatest lies: the check is in the mail, I will respect you in the morning,
and I am from the government and I am here to help. We have talked
about the check is in the mail. There is the promise that we will keep
your information confidential and not only that,. we have
anti-discrimination laws, and yes, I am with the government, and I am
here to help you. There is a good reason why those ate referred to as the
big three lies.
I think the main way of stopping name reporting, probably our
only way of stopping name reporting, is with some kind of coded unique
identifier proposal with appropriate safeguards built in so they cannot
take a unique identifier down to the Social Security Administration
records and find out who everybody is.
MR. WILLIAMS: Okay. We have another question for you.
What is likely to happen on the issue of HIV contactnotification?
1999] 491
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MR. GOTTFRIED: Thanks toNushawn Williamse and a couple
other people, including Assembly Member Nettie Mayersohn and
virtually every editorial board in the state, there is very strong pressure
for legislation to create something that goes by the name of mandatory
contact notification. It is one of those myths like unicorns. The notion
is that with sexually transmitted diseases, we have something called
mandatory partner notification. "If it is good enough for syphilis, why
are we treating HIV differently? It must be just politics." As if the
communities that are highest at risk for HIV are known to be politically
powerful in the New York legislature.
The truth is, mandatory contact notification is a myth in sexually
transmitted diseases. First of all, they do not even talk about contact
notification to people who have not chosen to come in to be tested.
Second of all, the only contacts we can even think about reaching out to
are the contacts that the infected person has voluntarily chosen to
disclose, since we neither torture people to give up names, nor do we
have a machine that reads their minds. Finally, if you carefully read the
STD statutes, there is no mandate on public health officials that they ask
you who your contacts are or that they go reach out to them. It is all
basically at their discretion.
On the other hand, while there is no such thing as mandatory
notification for STDs, the contact notification law in place for HIV is not
significantly different from what it is for syphilis. Doctors and public
health officials have a right in this state, as they always have, to notify
your known contacts with or without your consent.' Almost nobody in
this state knows that, but it is true. It is in the law. It was in the law
8 Nushawn Williams was a drifter who was accused of knowingly "spreading
HIV to 13 women in upstate New York in 1997." See Richard Perez-Pena, Drifter Gets 4-12
Years in HIV Case, N.Y. TIMES, Apr. 6, 1999, at B 1. He was described as "a sexual predator
who sometimes traded crack cocaine for sex, knowing that he had HIV. Id. It was reported
that Mr. Williams had sex with "at least 48 young women and girls in the area" and in
addition, he had told people he had "50 to 75 more sex partners in New York City." Id.
"Mr. Williams, 22, became the first person in New York, and one of only a handful around
the country, to face criminal charges for giving someone HIV." Id.
9 As of January 3, 1999 physicians in New York State no longer have this




before we enacted it in 1988, and it is still there. While it is not
"mandatory," it is not mandatory for syphilis, either. Nevertheless, there
is great pressure in the Legislature to do something that will be reported
as being mandatory partner notification.
As with name reporting, I think if you do that, the potential for
public health harm is enormous. If it frightens people away from being
tested by a healthcare practitioner who knows who they are and who
knows whether they are married or not or who their partner is; or if you
frighten them away from disclosing partners, then there will be less
partner notification in the future, not more. To give you a simple
example: When they contactedNushawn Williams and told him that his
name was given by someone who tested positive for syphilis, they told
him he really ought to get tested for HIV. What if Mr. Williams had said,
"thank you, no." Or what if he had agreed to be tested, but when they
asked him who he had sex with, instead of bragging about all the women
and girls in Jamestown he had sex with, he decided not to give them any
names. There would be all these women up inChautauqua County who
to this day and perhaps for many years would not know that they were
infected and would probably go on infecting others, and get pregnant and
bear HIV positive children. All of this could have resulted because public
officials, in a desire to look tough, had frightened him away from naming
names. So, I think that would be a terrible step backwards, but it is one
that is unfortunately very likely to happen.
MR. WILLIAMS: Kim, let's talk about the changing face of
HIV and AIDS, or the perceived changing face of HIV and AIDS. How
does this affect policies and practices for decreasing rates of HIV
infection or for providing services to people who are living with HIV and
AIDS?
Kimberly Mutcherson, Esq.
MS. MUTCHERSON: I think it is really important to the
terminology that we are accurate about women within this epidemic.
Women have always been a part of this epidemic and have consistently
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been ignored."° For a number of years, doctors have not recognized
ailments in women that are clear signs of HIV infection. We have seen
way too many women who are diagnosed very late in the disease, and
they are dying much faster than men are.
The statistics that we are looking at now, are pretty terrifying.
Between 1991 and 1995, the number of women diagnosed with AIDS
increased by sixty-three percent, compared with a 12.8 increase for
men." In June 1997 over ninety-two thousand women nationwide had
been diagnosed with AIDS.' 2 A large number of the women being
infected at this point are young and become infected through
heterosexual contact.
The women who are getting infected are also mostly women of
color: African American and Latina. 3 There are statistics that say that
the number of women of color who accounted for new AIDS patients in
1995, was seventy-seven percent. 4 These women represent seventy-six
percent of the cumulative total AIDS cases reported through December
1997. These are huge percentages for women who make up less than a
quarter of the women in this country.
At the same time that we are seeing this rise in the number of
women who are infected with HIV or are living with AIDS, we are also
seeing a lot of newspaper articles talking about HIV as a chronic, newly
"See Sheryl Gay Stolberg, Women and AIDS; The Better Half Got the Worse
End, N.Y.TIMEs, July 20, 1997, at Sec.4, P.1.
" See HIV Cases in Women May Soar, ALBUQUERQUE J., Apr. 22, 1998, at C3
(discussing a study funded by the Health Resource Center of New Mexico that indicated that
the number of U.S. women diagnosed with AIDS increased by 63 percent, which is more
than any other group).
12 See Deborah Kelly, AIDS Epidemic Shifting to Women Realizing Impact
Crucial, Expert Says, RICHMOND TIMES-DISPATCH, Mar. 20, 1999, at Al (citing several
AIDS facts, including a statistic indicating that by mid-1998, of the 665,000 AIDS diagnoses
in the United States, 104,000 had occurred in women).
3 See HIV Survival Gains Peak; But High Prevalence Among Disadvantaged
Means New Chronic Care Challenge, MED. & HEALTH, Oct. 26, 1998 (quoting the Centers
for Disease Control and Prevention stating that "the epidemic has increased most
dramatically among women of color" and that "African-American and Hispanic women
together represent less than one-fourth of all U.S. women, yet they account for more than
three-fourths (76 percent) of AIDS cases reported to date among women in our country.").
" See id.
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manageable disease, hailing the end of the epidemic. 5 Everything is
okay. We are all going to be fine. Ignoring 1), the fact that people are
still getting infected and to a different degree, and 2) also ignoring whom
those people are. I do not think that those two things are separate. I think
that problems tend to be ignored because of who those people are.
Because these things are happening at the same time, it is very
dangerous for women right now. We are seeing money starting to dry
up, because people are starting to talk about the end of the epidemic. 6
We are seeing this link between women and children, so that a program
that speaks of ending perinatal transmission or to reduce perinatal
transmission is also seen as a program that is dealing with women and
HIV as if those are the only women who we are concerned about it.
Women who are bearing children. There is a complete failure to
recognize and talk about the fact that, or a variety of reasons, not
everybody gets drug cocktails, and not everybody is a successful user of
those cocktails.
Particularly, when we talk about the ways in which women have
been excluded from a lot of the drug trials that study all of these
medications. Suddenly, they are finding that women do not respond as
well, or certain women do not respond as well. It was only in 1997 that
the Food and Drug Administration (FDA) proposed a rule that would
allow the agency to put a clinical hold on trials that exclude people based
on their reproductive potential. 7 The source of this rule was a concern
"See Diagnosis and Reporting ofHIVandAIDS in States with Integrated HIV
and AIDS Surveillance - United States, January 1994-June 1997, J. AM. MED. AW5'N, June
3, 1998 (cautioning that "[a]s a result of improvements in treatment and care of persons
infected with [HIV], surveillance of AIDS alone no longer accurately reflects the magnitude
or direction of the epidemic.")
6 See Bechetta Jackson, AIDS Activists Shift Focus as Quilt Comes to Chicago
Continued Vigilance, Funding are Stressed, CHIC. TRiB., Nov. 27, 1998, at 17 (expressing
activists' concerns over a drop in private donations, both locally and nationally, due to a
decrease in the number of people dying from AIDS and because people infected with the
disease are living longer); see also Stevenson Swanson, Drop in Donations Puts Aids
Groups at High Risk, CHIC. TRiB., July 19, 1999, § News, at 1.
17 See Investigational New Drug Applications; Proposed Amendment to Clinical
Hold Regulations for Products Intended for Life-Threatening Diseases, 62 Fed. Reg.49,946-
49,947 (1997) (to be codified at 21 C.F.R. pt. 312) (proposed Sept. 24, 1997). As of this
writing, the FDA still has not published the final clinical hold rule.
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about how many women were being left out of drug trials. This is
something that should have been addressed years ago.
The final thing that I think is happening, because there are more
women on the AIDS scene, is that we are starting to see a lot of programs
that are very punitive for women.' 8 Specifically, because women bear
children. Nobody wants to see a child with AIDS. So, a lot of programs
are geared toward ending perinatal transmission and not on focusing on
the health needs of the mother
MR. WILLIAMS: Kim, could you tell us about mandatory HIV
testing programs? Where do they exist and what are the problems?
MS. MUTCHERSON: The first thing I want to say is that my
interest in mandatory programs is very specific in terms of the work that
I do and the programs that I know about. New York has the dubious
honor of being the very first state in the country that has mandated HIV
testing of newborns.' 9 Since February 1997, every baby born in New
York State is tested for HIV, which a lot of people thought was a
wonderful thing. Why would you not want to do that? There are a
couple of things that I want to say as background before I start talking
about how it works, how it has been implemented and what some of the
flaws are.
The first things that we need to understand, which is not made
clear in a lot of the media reports that get out there, is that every single
baby born to a mom who is HIV positive is born with her mom's
antibodies. When a health care provider does an antibody test, he
discovers that this child was born to a mom who is HIV positive. It is not
a discovery that the child is HIV positive. You have to do more testing
in order to actually figure out if the child is positive. So, this testing
identifies HIV positive women. It does not give these women the
opportunity that most other people still have, which is to get anonymous
" See id.; see also Women on Trial, NEWSL. - PEOPLE'S MED. SOC'Y, Aug. 1,
1998, at 3 (explaining a proposed rule that could put a hold on drug trials that exclude
women for inappropriate reasons, such as reproductive potential).
"9 See Maternal and Child Health, N.Y. PuB. HEALTH LAW § 2500-f (Consol.
1999) (effective June 26, 1996).
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testing. So, when we come to a system of name reporting or a system of
mandatory partner notification, women who bear children in New York
have no choice but to be caught up in that system.
The other thing is the study that encouraged these kinds of
testing programs. It was called ACTG076 (AIDS Clinical Trial Group °
I think most people have probably heard of it, because it is being
bantered around a lot. The results of 076 were released in 1994.
Basically, it is a study of about four hundred and fifty women identified
by NIH. They were all relatively healthy, but they were HIV positive.
Their T cells were over two hundred, and they had little or no anti-
retroviral therapy prior to their pregnancy. The study participants started
taking AZT orally at between fourteen and thirty-four weeks of
pregnancy. They got it intravenously during labor, and their babies were
given AZT orally for six weeks after birth.
What the researchers found was that the rate of transmission
went from twenty-five percent to about eight percent?' So, about a two-
thirds reduction. What is important to recognize though, is that seventy-
five percent of babies born to moms who are HIV positive and who have
no drug intervention whatsoever are not HIV positive.22 So, sure it is
great to go from twenty-five percent to eight percent, but at the same
time, the assumption on the part of the uninformed public seems to be
that every single baby born to an HIV positive mom will be HIV positive
and will have AIDS. As though the deal is done.
Once the results of ACTG076 came out, it became very clear that
something needed to be done. The United States Public Health Service
(PHS) issued recommendations. Their recommendations were for
counseling of every woman who receives prenatal care. I do not think
that anyone is going to quibble with that. It is a wonderful idea, and it
should be done. In addition to counseling, the PHS suggested an offer
of voluntary testing for every woman in prenatal care. New York
20 See NATIONAL INSTITUTES OF HEALTH, YEAR 2000 PLAN FOR HIV-RELATED
RESEARCH: FACT SHEET ON AIDS RESEARCH AND MINORITY POPULATIONS, at 200 (visited
July 10, 1999) <http://www.nih.gov/od/oar> (discussing ACTG076).
21 Julie McKenna, Where Ignorance is Bliss: A Proposal for Mandatory HIV
Testing of Pregnant Women, 7 STAN. L. & POL'Y REv. 133, 135 (1996).221d_ at 134.
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decided to take that a step further.
Since February 1, 1997, every single baby born in New York
State has to be tested for HIV. 3 The program is backed by a number of
regulations.2 4  Every mother is supposed to get HIV counseling
prenatally. It is mandatory. It is standard for any woman who gets care
from a regulated provider (i.e., hospitals and birthing centers). The
prenatal testing continues to be governed by Article 27-F here in New
York.25
The second part of it, which is the mandatory newborn testing,
is not covered by Article 27-F. The state this new program, from the
requirements of 27-F, specifically so that providers did not need to get
informed consent before they tested the babies even though the
newborn's HIV test reveals the mother's HIV status.26
When a woman comes in for delivery, she is supposed to get pre-
test counseling. The health care providers are supposed to tell her, one,
that the testing is going to take place. Two, what a test result means.
Specifically that if the baby tests HIV positive, then the mother is
definitely positive and her child may or may not be positive. The child
needs to make a return trip for confirmatory testing. The testing takes
place, and then the woman is supposed to get post-test counseling, except
women who test negative. If the test result is negative, providers are not
required to do any extensive follow-up. So, you can be sitting around
your house three months after having your baby, worrying about what
happened with the HIV test.
If the test is positive, the provider must call the woman back to
the hospital, provide her with post-test counseling, and explain to her
what the test results mean.2 ' The provider is supposed to explain to her
23 See N.Y. Pun. HEALTH LAW, supra note 19, §2500-f.
24 Michele M. Contreras, New York's Mandatory HIV Testing of Newborns: A
Positive Step Which Results in Negative Consequences for Women and Their Children, 20
WOMEN'S RTs. L. REP. 21, 28 (1998) (discussing the regulating testing, counseling, tracking
and disclosure of HIV/AIDS test results).
25 N.Y. PUB. HEALTH LAW §2782 (Consol. 1999).
26 Eileen M. McKenna, Note: The Mandatory Testing of Newborns for HIV: Too
Much, Too Little, Too Late, 13 N.Y.L. SCH. J. HUM. RTs. 307, 315 (1997).
27 Martha A. Field, Testing for AIDS: Uses andAbuses, 16 AM. J. L. & MED.
34, 48 (1990) (asserting that post-test counseling should be implemented through law and
498 [Vol. XV
AIDS AND DISCRIMINATION
the need for confirmatory testing. The provider is supposed to offer to
help her with partner notification. They are supposed to provide referrals
to social services, and they are supposed to offer to transfer her test
results to her physician. They are supposed to talk to her about the
potential for discrimination based on her HIV status.
This was an un-funded mandate from the state. This kind of
program requires a great deal of work on the part of health care
providers. Of course, what happens is the legislature did not give people
money, training, or time to prepare for proper implementation. So, the
program was implemented poorly. Through a hotline that we have at our
agency where we get phone calls from women who have concerns and
through our lawsuit, we have identified significant problems with the
program.
We have been seeing women who are not getting any counseling
whatsoever. Who were not told that the testing was going to take place,
and get called back to the hospital some weeks after giving birth and are
told "by the way, we tested your baby for HIV, and you are HIV
positive." This is a particular problem with patients who are receiving
private healthcare. Private physicians do not think that their patients are
going to be HIV positive, so they do not worry about this. Providers are
not providing referrals to social services. They are not getting women
back into care. They are not making sure that if their patients are
homeless they have somewhere to live. They are not making sure that
their patients are getting money so that they can take care of themselves.
The regulations say that providers have to do these things.28 There are
confidentiality violations. We have a plaintiff who was told by her
doctor, one month after her baby was born and in the middle of the
hospital nursery, that her child had tested HIV positive. Our client had
no idea that there had even been testing.
We are also seeing an incredible delay in the return of HIV test
results.29 The whole point of this program is to test these babies and get
modeled after existing counseling regulations).
2 Leading Cases, 112 HARv. L. REv. 283, 289-90 (1998) (noting that the
Supreme Court has held that "under the ADA, an HIV-positive patient has the right to be
treated by a provider .... ").
29 Linda Farber Post, Unblinded Mandatory HIV Screening of Newborns: Care
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them into health care right away. The earliest we have seen women get
the results back is a week, and the longest we have seen is about five
weeks, which is just ridiculous. During that interim, particularly with
women who have not had counseling, they are breast-feeding. If you are
HIV positive and you are breast-feeding, you increase the chances of
transmitting HIV to your child. Women are not given the information
they need to make decisions about this.
The definition of "in care" that New York State came up with
was, a child was considered to be in care when he or she has had a
second PCR test.3" So, basically what that means is once they find out
the child is positive or not, they have done their job, which makes no
sense whatsoever. These children are not being tracked to ensure
adequate follow-up health care. The state is certainly not making sure
that the mother is getting follow-up care. We find that a very big
problem with this program is the inability or unwillingness to
acknowledge that children do not get up out of the hospital and walk
home by themselves. If they have a mother who is HIV positive, then
she needs to be in care as well. She needs to get treatment. She needs to
take care of herself in order to take care of her child. This program is not
doing what it is supposed to do to make sure that happens.
There is no adolescent protocol in this program. 3' There is no
specific way that providers are supposed to deal with, say, a thirteen or
fourteen year old. Not only does the adolescent have a baby,but then she
finds out that she is HIV positive.
The program completely ignores the success of voluntary
programs. The rate of prenatal transmission in the United States dropped
by about forty-two percent in the last few years. This is before any kind
or Coercion?, 16 CARDOZO L. REv. 169, 180 (1994) (asserting that "An additional serious
drawback to neonatal HIV screening is the delay in obtaining test results.').
30 The Polymerase Chain Reaction (PCR) test is the second test given in HIV
detection. See Tara C. Fappiano, Finding a Legal Remedy for the HIV-Positive Infant:
Wrongful Life and Lack ofInformed Consent Explored, 12 ST. JoHN's J.L. COMM. 205, 236
n.224 (1996).
3" Raymond C. O'Brien, An Argument for the Inclusion of Children Without
Medicare, 33 U. OF LouisVILLE J. OF FAM. L. 567, 618 (1994) (asserting that such
governmental programs as Medicaid and Medicare do not contain protocols for children and
exclude the children from care).
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of mandatory program. What that suggests to me, what it might suggest
to a lot of people, is that something was working, whether it was that
women were getting the information they needed so that they could get
medical treatment, or they discover that they are HIV positive and they
choose not to get pregnant. The point is that the rate of transmission is
already dropping. This program now completely ignores that history.
There is also the issue that was discussed in terms of HIV name
reporting, that is that it drives people away from the healthcare system.
The state is certainly not doing anything for a child if his or her mother
is frightened away from prenatal care or follow-up care. Mandatory
programs do that.
The last thing that I would say is that this program is a pathetic
substitute for a program that is concerned about women living with HIV.
This is a program that is concerned about women who have babies. Not
all women have babies. This is huge problem in general in terms of not
only New York's HIV/AIDS policy, but the State's and the country's
AIDS policy, as well.
New York right now is the only state that has mandatory
newborn testing.32 There are other states who have what is called right
of refusal testing. This means that a woman may choose not to be tested,
at which point she must sign a form saying, "I have been told that they
want to do this testing, and I am refusing this testing."33 Women might
refuse testing for a number of reasons, not the least of which is they
already know their status, so they do not want to have it put on another
medical form. It is possible this kind of testing will become national in
a few years. The reason for that is because the Ryan White Care Act
Reauthorization of 1996 contains a clause on perinatal transmission.34
32 Leonardo Renna, New York State's Proposal to Unblind HIV Testing for
Newborns: A Necessary Step in Addressing a Critical Problem, 60oBROOK. L. REv. 407, 408
(1994) (discussing New York State's mandatory testing). Since the date of this symposium,
Connecticut has joined New York in mandating HIV testing of newborns in certain
instances. See Act of June 14, 1999, §§ 30-32, 1999 Conn. Acts 99-2 (Spec. Sess.).
3 Suzanne M. Malloy, Mandatory HIV Screening of Newborns: A Proposition
Whose Time Has Not Yet Come, 45 AM. U. L. REv. 1185, 1186 n.10 (1996).
14 Theresa M. McGovern, Mandatory HIV Testing and Treating of Child-
Bearing Women: An Unnatural, Illegal, and Unsound Approach, 28 COLUM. HUM. RTS. L.
REv. 469, 470 (1997) (asserting that the 1996 Ryan White CARE Act Reauthorization Bill
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The Care Act requires that in the year 2000, states have to demonstrate
one of the following things, or they lose their entitlement to portions of
their Ryan White funding, which is a lot of money. States must show: a
fifty percent reduction in the number of AIDS cases resulting from
perinatal transmission; or a voluntary HIV testing rate of at least ninety-
five percent among pregnant women who make at least two prenatal
visits prior to their thirty-fourth week; or mandatory testing of all
newborns whose mothers have not had prenatal HIV testing. When
Congress creates such a high bar, states understand that they must have
mandatory testing or lose portions of their Ryan White Money.
The second thing that is going on is that Congress also required
the Institute of Medicine to conduct a study on barriers to further
reduction of the rate of prenatal transmission in this Country. After
completing its study, the Institute of Medicine (IOM) will make
recommendations on how to further declare the rate of prenatal
transmission. Some time in the next nine months, the IOM Committee
on Perinatal Transmission of HIV is going to tell Congress how to make
the rates of perinatal transmission go down. One of the things that they
could do is say, not only test all babies who are born, but test pregnant
women. When you test pregnant women, and you find out they are HIV
positive, then you can take better responses 5 Obviously mandatory HIV
testing of pregnant women also raises a host of disturbing issues.
MR. WILLIAMS: Thanks, Kim. Nina, you work in suburban
provides that each state has eighteen months to demonstrate "a fifty percent reduction in the
rate of new AIDS cases resulting from perinatal transmission.").
35 The IOM released a report that while not endorsing mandatory HIV testing
of pregnant women did endorse "universal" testing. See INSTITUTE OF MEDICINE, REDUCING
THE ODDS: PREVENTING PERINATAL TRANSMISSION OF HIV IN THE UNITED STATES 110
(Michael A. Soto et al. eds., 1999) (visited July 29, 1999) <http://books.nap.edu/
html/rto/pdf.html> (the URL provided is to the table of contents, from which you download
all cited text in PDF format). "The IOM recommends adoption of a national policy of
universal HIV testing, with patient notification as a routine component of prenatal care.
Routine and notification means that the test for HIV would be integrated into the standard
battery of prenatal tests, and that women would be informed that the HIV test is being
conducted and of their right to refuse it." Id. (Emphasis in original). Under this proposal
HIV testing would simply be added to the battery "of tests for which blood already is drawn,
such as a complete blood count, blood type, and syphilis." Id.
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Rockland County; is that right? Could you tell us about discrimination
in the healthcare system there and what you are doing to combat it?
Nina Loewenstein, Esq.
MS. LOEWENSTEIN: First I just want to add something to
what you were saying about the mandatory disclosure of HIV test results.
I have been working with the Lower Hudson HIV Care Network, and
health care and social services providers have reported to the Network
that there is very little prenatal HIV related counseling, particularly for
women in private care. Furthermore, the need for interpreters for Spanish
and Creole speaking women is as critical for HIV counseling upstate as
it is in the metropolitan area.
According to New York Department of Health statistics,
although the incidence of HIV in the Lower Hudson region is relatively
low compared to New York City, the proportion of HIV among women
of color is much, much higher.36 Eight and a half fold compared to
whites in New York City. In the rest of the state the difference is even
higher - fifteen fold. Of course, the statistics are not nicely broken down
into their country of origin. I think that in the upstate locations, a very
important aspect is understanding that you need to counsel women
effectively, including professional interpreters and culturally sensitive
information.
MR. WILLIAMS: Thankyou Nina. Jennifer, could you give us
a quick summary of whether or not asymptomatic HIV infected folksare
still covered by the Americans with Disabilities Act?
36 See NEW YORK STATE DEPARTMENT OF HEALTH, AIDS iN NEW YORK 14-17
(1997). For example, by December 1996 New York City's HIV infection rate for child
bearing women was averaging 1%. Id. at 14. At the same time, The infection rates for child
bearing women in the Nassau, Suffolk, Rockland, Westchester, Dutchess, Orange, Putnam,
Ulster and Sullivan counties was averaging between 0.15% and 0.2%. Id. During the same
period in New York City women of color made up between 0.6% and 1.7% of those infected,
while in the rest of New York State they made up between 0.2% and 0.8%. Id. at 15.
N.Y.L. SCH. J. HUM. RTS.
Jennifer Middleton, Esq.
MS. MIDDLETON: In the interest of time, I will be very brief.
I bet most of you thought that we have federal laws that ban
discrimination against people with HIV. Right? That used to be the case,
but currently there is a case in front of the United States Supreme Court
that questions that."'
The history of this case is the following. The Americans with
Disabilities Act, which prohibits discrimination against people with
disabilities, was passed in 1990. That is the law that activists have relied
upon to fight discrimination against people with HIV. Its definition of
someone who is covered under the law is a person with an impairment
that substantially limits his or her major life activity.3" That is the
definition of someone with a disability. There is another section of that
definition whereby you can be covered under the law if you are regarded
as having a disability, i.e., you are discriminated against even though you
do not actually have a disability, because the discriminator thought you
had some disability. 39
The definition has always been interpreted under its precursor
and under the ADA itself to cover people with HIV, whether they were
symptomatic or not. If you consider the definition though an impairment
which substantially limits a major life activity, it does not easily lend
itself to people who have not manifested any kind of symptoms and who
have not changed how they would otherwise live their life. So, defense
lawyers facingmore and more discriminationclaims filed by people with
HIV decided to go ahead and say, well, look at this definition. This
plaintiff is not a person with a disability.
The Fourth Circuit Court of Appeals out of Richmond, Virginia,
which covers three states, Virginia, North Carolina and Tennessee, if I
am correct, decided categorically last year that HIV, until it is
" See Bragdon v. Abbot, 118 S. Ct. 2196 (1998) (decided June 25, 1998)
(holding that AIDS is a disability under § 12102(2)(A) of the Americans With Disabilities
Act).
38 See id. at 2204.
'9 See Americans With Disabilities Act of 1990, 42 U.S.C. § 12101
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symptomatic, does not constitute a disability under the law.4 ° People
with asymptomatic HIV, then, were not protected against discrimination.
The First Circuit, in a similar case, decided differently. They held that
the ADA does cover a person with asymptomatic HIV.4
The First Circuit case is currently pending before the Supreme
Court. It is going to be argued on March 30th by Ben Klein of Gay and
Lesbian Advocates and Defenders in Boston. We are hopeful that there
will be a good outcome, but it really is kind of scary that the court is
considering the issue at all. The current Supreme Court typically reads
statutes closely and does not settle upon liberal interpretations. But, in
this case, we think the legislative and policy histories are sufficiently
clear. It may be that the court rules that the plaintiff will have to come
forward and demonstrate what major life activity they are in fact limited
in.
The current case in before the Court involves a woman who had
chosen not to have children because of her infection, so the easiest route
for the Court to take is to rule that her reproduction was limited by her
infection.42 If that is what they rule, we are going to have to come up
with creative ways of showing that HIV alters each individual's major
activities. It might not be that difficult, as anyone with HIV knows. Your
life completely changes, even if you do not have substantial symptoms.
I think the next battle may be pushing the courts to recognize the many
kinds of ways the disease limits peoples' lives.
Anyway, keep your eyes open because I hope there will be lots
of press attention when that case finally is decided.
MR. WILLIAMS: Thanks. Why don't we open it up to
questions from the floor.
AUDIENCE MEMBER. I just wondered if you could comment
on what causes of action a person has if their HIV status is disclosed. I
have a client who is an employee in a big hospital that is part of a very
40 See Runnebaum v. Nationsbank of Maryland, N.A., 123 F.3d 156 (4th Cir.
1997).
41 See Bragdon, 118 S. Ct. at 2201.
41 Id. at 2204.
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large network with a very large computer system. He was treated in the
hospital a couple of times for totally non-HIV related injuries. His HIV
status was known to his personal healthcare practitioner and was
confidential as far as he knew.
One day he goes to work, he presses a button on his computer,
and up comes his name with his HIV status plastered all over the place.
Anybody in the hospital can pull this up, and some people actually have.
Does he have a cause of action? The Department of Health has been
involved, and they do not know what to do. The hospital has said they
will do what they can to eliminate this problem., So, this has been going
on for some months and I do not know where to begin.
MR. WILLIAMS: Jennifer?
MS. MIDDLETON: I am actually going to pass this along
maybe to Kim or Nina, just because it is New York State Law. It is just
not my primary focus.
MS. MUTCHERSON: Article 27-F is the New York State law
that covers HIV testing , confidentiality, and disclosure.43 There are
certain instances in which HIV related informationcan be disclosed. To
have it come up on a computer for anyone to see does not fall into a
category where you can disclose the status. From what you said very
briefly, I do not know the specifics of it, but I would start with Article
27-F.
MR. GOTTFRIED: If you disclose confidential HIV information
in violation of the standards in the statute, you can certainly be sued for
damages." You can be subjected to criminal penalties. 5 If you are a
43 See N.Y. PuB. HEALTH LAW §§ 2781-82 (McKinney 1993). Article 27-F, §§
2781 and 2782 of the New York Public Health Law discuss HIV related testing,
confidentiality and disclosure, respectively. Id.
44 See N.Y. PuB. HEALTH LAW § 2783(l)(b) (McKinney 1993). Any person
who discloses confidential HIV related information in violation of § 2782 is subject to a civil
penalty not to exceed $5,000 for each occurrence. Id.
45 See N.Y. PuB. HEALTH LAW § 2783(2) (McKinney 1993). Any person who
"willfully [discloses confidential HIV related information in violation of § 2782] shall be
guilty of a misdemeanor .... " Id.
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licensed practitioner, it could be grounds for professional discipline.46
The threshold question is, was the data in this computer disclosed
in a way that violates the statute. Under the statute, for example, a
patient's medical record. People who do have a legitimate access to that
medical record for treating purposes can have access to it. So, it would
depend a lot on exactly what it was that enabled this client to get access
to this record, and then what kinds of other people have access to it. It
would depend a lot on the particulars.
MR. WILLIAMS: One more quick question.
AUDIENCE MEMBER: Did you Say that seventy-five percent
of mothers without medication deliver babies who are not HIV positive?
MS. MUTCHERSON: Every HIV positive mother delivers
babies with HIV antibodies, because babies are born with their mom's
antibodies. Seventy-five percent of those babies with subsequent HIV
testing - which tests for the actual virus rather than antibodies - are
actually HIV negative.
AUDIENCE MEMBER: Another thing you. had mentioned. I
think you commented that the state mandates seem to ignore the
downward trend of HIV infection among women. Do I understand that
correctly?
MS. MUTCHERSON: Right. Basically what we are seeing
nationwide is that the number of women who are delivering babies who
are HIV positive is decreasing.4 This mandatory testing program ignores
those numbers and presumes that women were not doing anything on
their own, or that healthcare workers are not doing anything to actually
46 See N.Y. EDUC. LAW § 6530 (McKinney 1993). If a licensee is found guilty
of a crime under New York state law, he or she is subject to penalties for professional
misconduct. Id.
47 See Martha Irvine, AZT Regimen, Regular Treatment Making a Difference,
L. A. DAILY NEWS, May 12, 1997, at L6 (discussing how the rate of HIV positive births has
recently decreased).
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effect the rate of HIV transmission. This program makes terrible
assumptions about women, what women are capable of and what they are
doing.
MR. GOTTFRIED: I would like to expand a little on that,
because I think there is a very important information lesson in those
numbers. One is that from the start of the epidemic and more so every
day, as far as we know, the number of women of childbearing age who
are infected has been going up steadily.4" But, since the early nineties,
the number of newborns who are born to infected women has been going
down steadily. Fewer and fewer infected women are giving birth, even
though the number of infected women continues to go up dramatically.
Something very good is happening out there that is alerting these women,
a), that they are infected and, b), that if you are infected you should think
at least twice if not more so before having a baby. The fact that that
number is going down so dramatically is very telling.
The other thing that is going down is the percentage of those
babies who are actually infected.49 What the 076 study told us is that
about twenty-five percent of the babies born to infected women are truly
infected." If the mother begins and follows the elaborate AZT regimen
early in pregnancy, the likelihood of the baby being infected goes from
twenty-five percent down to about eight percent"' Again, that is notjust
" See Deborah Kelly, AIDS Epidemic Shifting to Women; Realizing Impact
Crucial, Experts Says, RICHMOND TMfEs-DISPATCH, Mar. 20, 1999, at Al. The number of
women infected with the HIV virus is steadily increasing and occurs most often during their
childbearing years. Id.
49 See Juliet J. McKenna, Where Ignorance is not Bliss: A Proposal for
Mandatory HIV Testing of Pregnant Women, 7 STAN. L. & POL'Y REV. 133 (1996)
(discussing the decrease in rate of transmission of HIV from mother to child with the
introduction of AZT during pregnancy); see also Henry L. Davis, HIV Children Living
Longer, Face New Problems, BuFF. NEWS, Dec. 13, 1998, at Al. In the United States, the
number of babies infected with the HIV virus has dramatically decreased with the onset of
doctors treating HIV infected mothers with the drug AZT. Id.
51 See AZT May Save Babies from HIV of Mothers, PLAIN DEALER, Feb. 22,
1994, at 9A. According to the study conducted by the AIDS Clinical Trials Unit, 25.5
percent of those babies born to HIV infected mothers who were not treated with AZT were
born HIV infected. Id.
See Jennifer Cooper, The Politics of Pediatric AIDS, 3 CAkDOZO WOMEN'S
L.J. 53, 60 (1996). Results of the ACTG 076 study revealed that 8.3 percent of the babies
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a matter of getting women tested early in pregnancy. It is a matter of
making available to them and encouraging them to participate in a very
complicated, difficult drug regimen. That does not happen automatically.
That happens because the women not only know their HIV status,but
know that treatment is available and have enough confidence in their
prenatal care provider to buy into that treatment regimen. The same thing
is true for treatment for the newborn at birth.
MS. MUTCHERSON: I think it is very import to point out the
disparity in treatment for pregnant women. One of the things that come
up with AZT is that no one who is getting really great healthcare is just
on AZT anymore. Proper healthcare for an HIV positive patient requires
being on a multiple drug regimen. Asking pregnant women to take only
AZT is asking them to engage in a sub-optimal treatment regimen.
MR. WILLIAMS: Well, I would like to thank the panelists very
much for their participation. This was very informative. Thank you all.
born to HIV positive mothers who received AZT during pregnancy were HIV positive, while
25.5 percent of the babies born to HIV positive mothers who were given a placebo during
pregnancy were HIV positive. Id. See also Martha Irvine, Mother-to-Baby HIV Curbed with
C-Sections and AZT, SAN DIEGO UNION-TRiB., June 28, 1998, at A9. With the use of AZT
during pregnancy, the chance of a baby being born HIV positive decreases from 25 percent
to 8 percent. Id.
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